These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunoprophylaxis for influenza: comparison of a subunit and a whole virion vaccine. Carle F; Bolgiani M; Zanon P; Moiraghi Ruggenini A; Zotti C Boll Ist Sieroter Milan; 1988; 67(2):105-15. PubMed ID: 3067735 [TBL] [Abstract][Full Text] [Related]
27. New data on influenza vaccines in children. Block SL Pediatr Infect Dis J; 2004 Jan; 23(1):85. PubMed ID: 14743058 [No Abstract] [Full Text] [Related]
28. Parental attitude toward influenza A(H1N1)v vaccination in Italy. Tozzi AE; Gesualdo F; Romano M; Caione D Vaccine; 2009 Nov; 27(49):6807. PubMed ID: 19781680 [No Abstract] [Full Text] [Related]
30. [Influenza]. Bol P Ned Tijdschr Tandheelkd; 2003 Mar; 110(3):132-3. PubMed ID: 12680345 [No Abstract] [Full Text] [Related]
31. [Influenza vaccination of children with hemophilia]. Klukowska A; Brydak L; Rokicka-Milewska R; Gosk B; Wielopolska M; Adamowicz-Salach A; Rudnicka H; Regnery H; Cox N Acta Haematol Pol; 1995; 26(3):305-10. PubMed ID: 8525777 [TBL] [Abstract][Full Text] [Related]
32. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks. Buxton JA; Skowronski DM; Ng H; Marion SA; Li Y; King A; Hockin J J Infect Dis; 2001 Jul; 184(2):188-91. PubMed ID: 11424016 [TBL] [Abstract][Full Text] [Related]
33. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines]. Sarateanu DE; Ehrengut W Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399 [No Abstract] [Full Text] [Related]
34. [Vaccination against influenza in the aged and high-risk persons]. Rossi G Recenti Prog Med; 2002 Dec; 93(12):665-6. PubMed ID: 12557794 [No Abstract] [Full Text] [Related]
35. Resistance of mice immunized per os with A2 influenza virus to intranasal challenge with a pathogenic strain. Sidorova LA; Alekseyeva AK Acta Virol; 1973 Jul; 17(4):298-304. PubMed ID: 4148209 [No Abstract] [Full Text] [Related]
36. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination]. Stumpa A; Tůmová B Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986 [No Abstract] [Full Text] [Related]